The Scientist

» clinical trials and microbiology

Most Recent

image: The Energy of Life

The Energy of Life

By | February 1, 2015

Extremophiles should not be viewed through an anthropocentric lens; what’s extreme for us may be a perfectly comfortable environment for a microbe.

3 Comments

image: Tamiflu Reviewed Again

Tamiflu Reviewed Again

By | January 30, 2015

The controversial antiviral drug earns better marks in the most recent analysis of the evidence. 

1 Comment

image: UV Light Doesn’t Fully Purify

UV Light Doesn’t Fully Purify

By | January 28, 2015

Using ultraviolet light to disinfect drinking water may simply drive bacteria to dormancy, rather than kill them.

0 Comments

image: Ebola Update

Ebola Update

By | January 26, 2015

Vaccine trial to start in Liberia as early as next week; trial for experimental therapy also planned, but production is still limited

1 Comment

image: GMO “Kill Switches”

GMO “Kill Switches”

By | January 21, 2015

Scientists design bacteria reliant upon synthetic amino acids to contain genetically modified organisms.

6 Comments

image: IOM Urges Data Sharing

IOM Urges Data Sharing

By | January 15, 2015

The Institute of Medicine says results from human clinical trials ought to be made available to independent researchers within 18 months.

0 Comments

image: 23andMe Partners with Pfizer

23andMe Partners with Pfizer

By | January 13, 2015

The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.

1 Comment

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

image: Picturing Infection

Picturing Infection

By | January 1, 2015

Whole-animal, light-based imaging of infected small mammals

4 Comments

image: The Year in Pathogens

The Year in Pathogens

By | December 29, 2014

Ebola, MERS, and enterovirus D68; polio eradication efforts; new regulations on potentially dangerous research

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS